Subsequently, sections of the tumor blocks were stained with Ki67, or PARP antibody (1:500 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA) by the pathology core facility. The gene discussed is PARP1; the disease is neoplasm.